BNP Paribas Financial Markets Buys 409,938 Shares of BioCryst ...

Dec 5, 2024 · BNP Paribas Financial Markets’ holdings in BioCryst Pharmaceuticals were worth $3,776,000 at the end of the most recent reporting period. Other hedge funds have also …

$3776000
OFF

BNP Paribas Financial Markets Buys 409,938 Shares Of BioCryst ...

2 weeks from now

Dec 5, 2024 · BNP Paribas Financial Markets’ holdings in BioCryst Pharmaceuticals were worth $3,776,000 at the end of the most recent reporting period. Other hedge funds have also …

etfdailynews.com

0%
OFF

BNP Paribas Financial Markets Buys 409,938 Shares Of BioCryst ...

2 weeks from now

Dec 5, 2024 · BNP Paribas Financial Markets raised its stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 472.0% in the third quarter, according to the company in …

americanbankingnews.com

0%
OFF

Two Sigma Advisers LP Acquires 261,500 Shares Of BioCryst ...

2 weeks from now

Dec 9, 2024 · BNP Paribas Financial Markets lifted its position in shares of BioCryst Pharmaceuticals by 472.0% in the third quarter. BNP Paribas Financial Markets now owns …

marketbeat.com

$3.79
OFF

BNP Paribas Financial Markets Purchases 28,822 Shares Of John B ...

2 weeks from now

Dec 5, 2024 · BNP Paribas Financial Markets Buys 409,938 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) NEXT HEADLINE » BNP Paribas Financial Markets Has $3.79 Million …

etfdailynews.com

€5
OFF

BNP Paribas Signs Deal To Buy AXA IM For €5.1bn

2 weeks from now

Dec 23, 2024 · French banking giant BNP Paribas has purchased the investment management arm of AXA for €5.1bn, taking over €850bn of assets under management. BNP Paribas signs …

sharecast.com

5%
OFF

BNP Paribas Financial Markets Buys 38,434 Shares Of Verona …

2 weeks from now

Dec 8, 2024 · BNP Paribas Financial Markets boosted its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 176.5% during the 3rd quarter, according to the company …

marketbeat.com

5%
OFF

BNP Paribas Financial Markets Acquires 99,685 Shares Of Integra ...

2 weeks from now

Dec 8, 2024 · BNP Paribas Financial Markets boosted its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 824.5% during the third quarter, according to …

marketbeat.com

8%
OFF

BNP Paribas Financial Markets Buys 46,798 Shares Of CareDx, Inc …

2 weeks from now

Dec 9, 2024 · BNP Paribas Financial Markets raised its position in CareDx, Inc (NASDAQ:CDNA - Free Report) by 1,784.8% in the third quarter, according to its most recent Form 13F filing with …

marketbeat.com

2%
OFF

BNP Paribas Financial Markets Acquires 118,868 Shares Of F.N.B.

2 weeks from now

Dec 8, 2024 · BNP Paribas Financial Markets increased its stake in shares of F.N.B. Co. (NYSE:FNB - Free Report) by 527.2% in the third quarter, according to the company in its …

marketbeat.com

3%
OFF

Rogers Communications Inc. (NYSE:RCI) Shares Acquired By BNP …

2 weeks from now

Dec 9, 2024 · BNP Paribas Financial Markets boosted its position in shares of Rogers Communications Inc. (NYSE:RCI - Free Report) TSE: RCI.B by 107.3% in the third quarter, …

marketbeat.com

FAQs about BNP Paribas Financial Markets Buys 409,938 Shares of BioCryst ... Coupon?

Does BNP Paribas own BioCryst Pharmaceuticals?

BNP Paribas Financial Markets’ holdings in BioCryst Pharmaceuticals were worth $3,776,000 at the end of the most recent reporting period. Other hedge funds have also recently added to or reduced their stakes in the company. CWM LLC grew its holdings in BioCryst Pharmaceuticals by 200.0% during the 2nd quarter. ...

Who owns BioCryst Pharmaceuticals?

Mirae Asset Global Investments Co. Ltd. now owns 7,483 shares of the biotechnology company’s stock valued at $57,000 after purchasing an additional 1,322 shares during the last quarter. nVerses Capital LLC bought a new position in shares of BioCryst Pharmaceuticals in the 2nd quarter valued at about $63,000. ...

What is the market value of BNP Paribas in USD?

BNP Paribas has a market value of $81 billion in USD. ...

Does signaturefd LLC own BioCryst Pharmaceuticals?

Signaturefd LLC boosted its stake in shares of BioCryst Pharmaceuticals by 560.5% in the 2nd quarter. Signaturefd LLC now owns 6,598 shares of the biotechnology company’s stock valued at $41,000 after purchasing an additional 5,599 shares during the last quarter. ...

Does Mirae Asset global invest in BioCryst Pharmaceuticals?

Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of BioCryst Pharmaceuticals by 21.5% in the 3rd quarter. ...

Does Cwm LLC own BioCryst Pharmaceuticals?

CWM LLC grew its holdings in BioCryst Pharmaceuticals by 200.0% during the 2nd quarter. CWM LLC now owns 5,658 shares of the biotechnology company’s stock worth $35,000 after acquiring an additional 3,772 shares during the last quarter. Signaturefd LLC boosted its stake in shares of BioCryst Pharmaceuticals by 560.5% in the 2nd quarter. ...